Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
02/27/2015 03/02/2015 03/03/2015 03/04/2015 03/05/2015 Date
3083.1(c) 3100(c) 3115(c) 3160(c) 3273 Last
9 148 10 923 11 322 10 313 37 837 Volume
-0.58% +0.55% +0.48% +1.44% +3.58% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
04/28Earnings Release
More about the company
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2015 33 473 M
EBIT 2015 6 057 M
Net income 2015 4 763 M
Debt 2015 -
Yield 2015 1,88%
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 55,86
PER 2016 -
Capi. / Sales 2015 7,94x
Capi. / Sales 2016 -
Capitalization 265 934 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
03/04 GLAXOSMITHKLINE : India pharmaceutical giant buys Glaxo's Aussie opiates busines..
03/04 GLAXOSMITHKLINE PHARMACEUTICALS : Sun Pharma to buy GSK's Opiates biz in Austral..
03/02 GlaxoSmithKline To Set Out Guidance When It Reports On May 6
02/18 GLAXOSMITHKLINE PHARMACEUTICALS : Shanghai official linked to GSK bribery senten..
02/18 GLAXOSMITHKLINE PHARMACEUTICALS : Promotes Jack Bailey As President For North Am..
02/17 Gsk pharma to transfer cancer portfolio to novartis arm
02/17 GLAXOSMITHKLINE PHARMACEUTICALS : Gsk pharma to shift cancer drug portfolio to n..
02/13 GLAXOSMITHKLINE PHARMACEUTICALS : Pharma q3 net declines 61%
More news
Sector news Pharmaceuticals - NEC
01:07p Wall St little changed after 2-day drop, data
01:01pDJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 4th Update
12:47p AbbVie CEO says new form of Humira could thwart generics
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF